Mechanisms and clinical importance of bacteriophage resistance
Julia Egido (University Medical Center Utrecht)
A.R. Martins Costa (TU Delft - BN/Stan Brouns Lab, Kavli institute of nanoscience Delft)
C. Aparicio Maldonado (Kavli institute of nanoscience Delft, TU Delft - BN/Stan Brouns Lab)
More Info
expand_more
Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.
Abstract
We are in the midst of a golden age of uncovering defense systems against bacteriophages. Apart from the fundamentalinterest in these defense systems, and revolutionary applications that have been derived from them (e.g. CRISPR-Cas9 andrestriction endonucleases), it is unknown how defense systems contribute to resistance formation against bacteriophagesin clinical settings. Bacteriophages are now being reconsidered as therapeutic agents against bacterial infections due the
emergence of multidrug resistance. However, bacteriophage resistance through defense systems and other means couldhinder the development of successful phage-based therapies. Here, we review the current state of the field of bacteriophagedefense, highlight the relevance of bacteriophage defense for potential clinical use of bacteriophages as therapeutic agentsand suggest new directions of research.
help_outline